Skip to main content
. 2014 Aug 25;17(2):243–253. doi: 10.1093/neuonc/nou217

Table 1.

Clinicopathological parameters of 45 glioma samples from the Second Affiliated Hospital of Harbin Medical University

No. Age Sex Pathology (WHO) No. Age Sex Pathology (WHO)
01 31 Female Astrocytoma II 24 45 Male Astrocytoma II
02 54 Male Glioblastoma IV 25 34 Female Astrocytoma I
03 36 Female Astrocytoma II 26 49 Female Glioblastoma IV
04 45 Male Astrocytoma III 27 47 Male Oligodendroglioma II
05 51 Male Glioblastoma IV 28 50 Male Glioblastoma IV
06 48 Female Astrocytoma II 29 43 Male Astrocytoma II
07 63 Female Astrocytoma III 30 31 Male Glioblastoma IV
08 50 Female Glioblastoma IV 31 52 Female Glioblastoma IV
09 59 Male Glioblastoma IV 32 41 Male Glioblastoma IV
10 40 Male Astrocytoma III 33 50 Female Astrocytoma III
11 45 Male Oligodendroglioma II 34 56 Female Glioblastoma IV
12 52 Male Astrocytoma II 35 59 Male Astrocytoma III
13 6 Male Glioblastoma IV 36 58 Female Glioblastoma IV
14 47 Male Glioblastoma IV 37 20 Male Astrocytoma III
15 9 Female Astrocytoma I 38 49 Female Glioblastoma IV
16 44 Female Astrocytoma II 39 40 Male Astrocytoma I
17 49 Male Astrocytoma II 40 15 Female Astrocytoma III
18 42 Male Oligodendroglioma II 41 31 Male Astrocytoma III
19 8 Male Astrocytoma III 42 62 Female Glioblastoma IV
20 9 Male Astrocytoma II 43 36 Male Glioblastoma IV
21 45 Female Astrocytoma III 44 40 Male Astrocytoma III
22 42 Female Astrocytoma III 45 63 Female Astrocytoma III
23 28 Female Astrocytoma II

Abbreviation: WHO, World Health Organization.